BCL2 and B-cell chronic lymphocytic leukemia: The deletion of 13q14 in B-CLL patients results to downregulation of miR-15a-5p and miR-16-5p levels and high levels of its targets, BCL2 and MCL1 anti-apoptotic proteins, leading to a reduction of apoptosis.